XML 19 R4.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance at Apr. 30, 2024 $ 54,760 $ 7,273 $ 5,406 $ (2,051) $ 47,514 $ (3,382)
Net earnings attributable to Kewaunee Scientific Corporation 2,193       2,193  
Other comprehensive loss (116)         (116)
Stock-based compensation (814) 80 (894)      
Ending balance at Jul. 31, 2024 56,023 7,353 4,512 (2,051) 49,707 (3,498)
Beginning balance at Apr. 30, 2024 54,760 7,273 5,406 (2,051) 47,514 (3,382)
Net earnings attributable to Kewaunee Scientific Corporation 6,555          
Other comprehensive loss (454)          
Ending balance at Jan. 31, 2025 60,801 7,353 5,266 (2,051) 54,069 (3,836)
Beginning balance at Jul. 31, 2024 56,023 7,353 4,512 (2,051) 49,707 (3,498)
Net earnings attributable to Kewaunee Scientific Corporation 3,008       3,008  
Other comprehensive loss (76)         (76)
Stock-based compensation 373   373      
Ending balance at Oct. 31, 2024 59,328 7,353 4,885 (2,051) 52,715 (3,574)
Net earnings attributable to Kewaunee Scientific Corporation 1,354       1,354  
Other comprehensive loss (262)         (262)
Stock-based compensation 381   381      
Ending balance at Jan. 31, 2025 60,801 7,353 5,266 (2,051) 54,069 (3,836)
Beginning balance at Apr. 30, 2025 64,457 7,353 5,635 (3,647) 58,919 (3,803)
Net earnings attributable to Kewaunee Scientific Corporation 3,093       3,093  
Other comprehensive loss (410)         (410)
Stock-based compensation (62) 68 (130)      
Ending balance at Jul. 31, 2025 67,078 7,421 5,505 (3,647) 62,012 (4,213)
Beginning balance at Apr. 30, 2025 64,457 7,353 5,635 (3,647) 58,919 (3,803)
Net earnings attributable to Kewaunee Scientific Corporation 6,230          
Other comprehensive loss (964)          
Ending balance at Jan. 31, 2026 70,675 7,423 6,517 (3,647) 65,149 (4,767)
Beginning balance at Jul. 31, 2025 67,078 7,421 5,505 (3,647) 62,012 (4,213)
Net earnings attributable to Kewaunee Scientific Corporation 2,445       2,445  
Other comprehensive loss (164)         (164)
Stock-based compensation 493 2 491      
Ending balance at Oct. 31, 2025 69,852 7,423 5,996 (3,647) 64,457 (4,377)
Net earnings attributable to Kewaunee Scientific Corporation 692       692  
Other comprehensive loss (390)         (390)
Stock-based compensation 521 0 521      
Ending balance at Jan. 31, 2026 $ 70,675 $ 7,423 $ 6,517 $ (3,647) $ 65,149 $ (4,767)